eperisone has been researched along with Chronic Pain in 3 studies
eperisone : A racemate that is an equimolar mixture of (R)- and (S)-eperisone. It is used (as the hydrochloride salt) as a muscle relaxant for the symptomatic treatment of muscle spasm and spasticity.
1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one : An aromatic ketone that is N-propylpiperidine in which a hydrogen at positon 2 of the propyl group is replaced by a p-ethylbenzoyl group.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate whether respectively radial extracoporeal shock wave therapy (rESWT) or a combination of rESWT, celecoxib and eperisone (rESWT + C + E) are superior in reducing pain in patients with chronic nonspecific low back pain (cnsLBP) compared to C + E alone (a standard treatment of this condition in China)." | 9.41 | Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. ( Feng, Z; Guo, X; Li, L; Li, Y; Peng, Z; Schmitz, C; Yan, Z; Yang, Y; Zhang, Y, 2021) |
"Eperisone, an analgesic and centrally acting muscle relaxant has been in use for the treatment of low back pain (LBP)." | 8.93 | Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. ( Ali Kareem, S; Bavage, S; Dhadde, SB; Durg, S, 2016) |
"To investigate whether respectively radial extracoporeal shock wave therapy (rESWT) or a combination of rESWT, celecoxib and eperisone (rESWT + C + E) are superior in reducing pain in patients with chronic nonspecific low back pain (cnsLBP) compared to C + E alone (a standard treatment of this condition in China)." | 5.41 | Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. ( Feng, Z; Guo, X; Li, L; Li, Y; Peng, Z; Schmitz, C; Yan, Z; Yang, Y; Zhang, Y, 2021) |
"Eperisone, an analgesic and centrally acting muscle relaxant has been in use for the treatment of low back pain (LBP)." | 4.93 | Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. ( Ali Kareem, S; Bavage, S; Dhadde, SB; Durg, S, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Guo, X | 1 |
Li, L | 1 |
Yan, Z | 1 |
Li, Y | 1 |
Peng, Z | 1 |
Yang, Y | 1 |
Zhang, Y | 1 |
Schmitz, C | 1 |
Feng, Z | 1 |
Bavage, S | 1 |
Durg, S | 1 |
Ali Kareem, S | 1 |
Dhadde, SB | 1 |
Rossi, M | 1 |
Ianigro, G | 1 |
Liberatoscioli, G | 1 |
Di Castelnuovo, A | 1 |
Grimani, V | 1 |
Garofano, A | 1 |
Camposarcone, N | 1 |
Nardi, LF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Prospective, Randomized, Controlled, Single Centre Trial to Assess the Efficacy and Safety of Radial Extracorporeal Shock Wave Therapy in Patients With Chronic Non-specific Low Back Pain[NCT03337607] | 150 participants (Anticipated) | Interventional | 2017-11-13 | Recruiting | |||
Comparative Effects of Shockwave Therapy and Maitland's Lumbar Mobilization on Pain, Disability and Range of Motion in Patients With Mechanical Low Back Pain[NCT05404997] | 26 participants (Anticipated) | Interventional | 2022-03-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for eperisone and Chronic Pain
Article | Year |
---|---|
Clinical efficacy and safety of eperisone for low back pain: A systematic literature review.
Topics: Chronic Pain; Clonidine; Humans; Low Back Pain; Pain Measurement; Propiophenones; Treatment Outcome | 2016 |
2 trials available for eperisone and Chronic Pain